Bioventix (LON:BVXP) Hits New 1-Year Low - What's Next?

Bioventix PLC (LON:BVXP - Get Free Report) shares reached a new 52-week low on Monday . The company traded as low as GBX 2,200 ($28.80) and last traded at GBX 2,490 ($32.59), with a volume of 13478 shares changing hands. The stock had previously closed at GBX 2,399 ($31.40).

Bioventix Price Performance

The firm's 50-day simple moving average is GBX 2,745.59 and its 200 day simple moving average is GBX 3,258.28. The firm has a market cap of £128.29 million, a P/E ratio of 15.85 and a beta of 0.35.

Bioventix (LON:BVXP - Get Free Report) last announced its quarterly earnings results on Monday, March 31st. The biotechnology company reported GBX 72.27 ($0.95) earnings per share for the quarter. Bioventix had a return on equity of 69.09% and a net margin of 59.51%. As a group, analysts forecast that Bioventix PLC will post 166.3066955 earnings per share for the current year.

Bioventix Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Friday, April 25th. Shareholders of record on Thursday, April 10th will be given a GBX 70 ($0.92) dividend. The ex-dividend date of this dividend is Thursday, April 10th. This represents a yield of 2.95%. Bioventix's payout ratio is currently 102.19%.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.